ΔVO₂ (ml/min), ΔVO₂/HR and ΔVE/VCO₂ slope baseline and post CRT+MRT, CRT and RUHB. حسب Sergio R. Thomaz (20308465)

الموضوعات:

Clinical characteristics of the study population. حسب Sergio R. Thomaz (20308465)

الموضوعات:

Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- حسب Wencheng Jin (13136262)

The screening process of MN705. حسب Wencheng Jin (13136262)

Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis. حسب Wencheng Jin (13136262)

Changes related to kidney staining in UUO mouse model. حسب Wencheng Jin (13136262)

Changes associated with kidney fibrosis in TGF- حسب Wencheng Jin (13136262)

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- حسب Wencheng Jin (13136262)

Effect of MN705 treatment on TGF- حسب Wencheng Jin (13136262)

Development of hamstring strength throughout the LIST. حسب Dominic Michael Rasp (19959412)

Development of the limb symmetry index (LSI) over the course of the LIST. حسب Dominic Michael Rasp (19959412)

Fig 3 - حسب Maha Rehman (17114332)

Growth of <i>Spirulina</i> spp. at 450nm for different temperature. حسب Maha Rehman (17114332)

Fig 5 - حسب Maha Rehman (17114332)

Fig 4 - حسب Maha Rehman (17114332)

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"

Study flow chart. حسب Benjamin R. Lewis (22279166)

"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"

Baseline characteristics of the study sample^βμ. حسب Osama Mohamed Ibrahim (12006954)

"…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …"

The flow diagram of the study (CONSORT, 2010). حسب Osama Mohamed Ibrahim (12006954)

"…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …"